Kevan Shokat (IMAGE)

Howard Hughes Medical Institute

Kevan Shokat

Caption

HHMI Investigator Kevan Shokat’s breakthrough in drugging the once-“undruggable” K-Ras protein has opened a new therapeutic path now reaching clinical trials, offering hope for treating cancers with notoriously poor survival rates.

Credit

Alison Yin / AP Images for HHMI

Usage Restrictions

Credit: Alison Yin / AP Images for HHMI

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.